HeXun Biosciences Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021
Period Ending	Dec '24 Dec 19, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	3,519	2,981	-	-
Enterprise Value	3,275	2,763	-	-
Last Close Price	76.50	64.80	-	-
PE Ratio	28.36	89.01	-	-
PS Ratio	14.90	22.83	-	-
PB Ratio	6.39	6.30	-	-
P/TBV Ratio	6.58	6.79	-	-
P/FCF Ratio	116.28	132.95	-	-
P/OCF Ratio	51.29	69.18	-	-
EV/Sales Ratio	13.85	21.16	-	-
EV/EBITDA Ratio	23.87	64.08	-	-
EV/EBIT Ratio	28.17	100.94	-	-
EV/FCF Ratio	108.21	123.24	-	-
Debt / Equity Ratio	0.06	0.15	0.23	0.35
Debt / EBITDA Ratio	0.25	1.56	13.75	-
Debt / FCF Ratio	1.12	3.24	7.16	-
Asset Turnover	0.42	0.27	0.14	-
Quick Ratio	12.11	11.67	9.82	10.87
Current Ratio	12.69	12.05	10.55	11.94
Return on Equity (ROE)	25.43%	8.50%	-1.96%	-
Return on Assets (ROA)	12.81%	3.51%	-1.61%	-
Return on Capital (ROIC)	13.38%	3.67%	-1.66%	-
Earnings Yield	3.53%	1.12%	-	-
FCF Yield	0.86%	0.75%	-	-
Buyback Yield / Dilution	-10.22%	-20.81%	-22.92%	-
Total Shareholder Return	-10.22%	-20.81%	-22.92%	-

Source: S&P Capital IQ. Standard template. Financial Sources.